Quantitative standardized estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) for prognostic and/or predictive index for response to adjuvant aromatase inhibitors exemestane or anastrozole

Project Details

StatusFinished
Effective start/end date1/12/17 → 30/11/22

Funding

  • Non-EU other: £54,054.00